IMTE vs ZKIN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 28, 2026

IMTE

30.0
AI Score
VS
ZKIN Wins

ZKIN

34.5
AI Score

Investment Advisor Scores

IMTE

30score
Recommendation
AVOID NEW MONEY

ZKIN

35score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric IMTE ZKIN Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -85.6% -43.5% ZKIN
Earnings Growth 0.0% -97.7% IMTE
Tradestie Score 30.0/100 34.5/100 ZKIN
Profit Margin 0.0% -28.0% IMTE
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY EXTENDED ZKIN

Relative Price Performance (Last 90 Days)

IMTE 1M: -5.4% · 3M: -13.1% ZKIN 1M: +45.2% · 3M: +32.4%

Current Technical Phase

IMTE

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.7%), weak momentum, RSI 42

RSI (14): 42.1 · Price: $0.45

ZKIN

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.5% over 20 days), RSI 59

RSI (14): 59.3 · Price: $1.80

Fundamentals Snapshot

Metric IMTE ZKIN
Market Cap — —
Forward P/E 0.0 0.0
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.9% -0.4%
Gross Margin -3.4% 0.1%
Operating Margin -61.8% -8.0%
EPS -0.08 -1.54
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ZKIN is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.